Trial Profile
Efficacy of natalizumab in patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Sep 2014 New trial record